An X-Linked Hyper-IgM Patient Followed Successfully for 23 Years without Hematopoietic Stem Cell Transplantation

When caring for patients with life-limiting diseases, improving survival and optimizing quality of life are the primary goals. For patients with X-linked hyper-IgM syndrome (XHIGM), the treatment modality has to be decided for a particular patient regarding hematopoietic stem cell transplantation or...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutukculer, Necil, Karaca, Neslihan Edeer, Aksu, Guzide, Aykut, Ayca, Pariltay, Erhan, Cogulu, Ozgur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204170/
https://www.ncbi.nlm.nih.gov/pubmed/30405923
http://dx.doi.org/10.1155/2018/6897935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204170/
https://www.ncbi.nlm.nih.gov/pubmed/30405923
http://dx.doi.org/10.1155/2018/6897935

Ejemplares similares